Cargando…

Structure of tyrosine aminotransferase from Leishmania infantum

The trypanosomatid parasite Leishmania infantum is the causative agent of visceral leishmaniasis (VL), which is usually fatal unless treated. VL has an incidence of 0.5 million cases every year and is an important opportunistic co-infection in HIV/AIDS. Tyrosine aminotransferase (TAT) has an importa...

Descripción completa

Detalles Bibliográficos
Autores principales: Moreno, M. A., Abramov, A., Abendroth, J., Alonso, A., Zhang, S., Alcolea, P. J., Edwards, T., Lorimer, D., Myler, P. J., Larraga, V.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: International Union of Crystallography 2014
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014323/
https://www.ncbi.nlm.nih.gov/pubmed/24817714
http://dx.doi.org/10.1107/S2053230X14007845
_version_ 1782315154903400448
author Moreno, M. A.
Abramov, A.
Abendroth, J.
Alonso, A.
Zhang, S.
Alcolea, P. J.
Edwards, T.
Lorimer, D.
Myler, P. J.
Larraga, V.
author_facet Moreno, M. A.
Abramov, A.
Abendroth, J.
Alonso, A.
Zhang, S.
Alcolea, P. J.
Edwards, T.
Lorimer, D.
Myler, P. J.
Larraga, V.
author_sort Moreno, M. A.
collection PubMed
description The trypanosomatid parasite Leishmania infantum is the causative agent of visceral leishmaniasis (VL), which is usually fatal unless treated. VL has an incidence of 0.5 million cases every year and is an important opportunistic co-infection in HIV/AIDS. Tyrosine aminotransferase (TAT) has an important role in the metabolism of trypanosomatids, catalyzing the first step in the degradation pathway of aromatic amino acids, which are ultimately converted into their corresponding l-2-oxoacids. Unlike the enzyme in Trypanosoma cruzi and mammals, L. infantum TAT (LiTAT) is not able to transaminate ketoglutarate. Here, the structure of LiTAT at 2.35 Å resolution is reported, and it is confirmed that the presence of two Leishmania-specific residues (Gln55 and Asn58) explains, at least in part, this specific reactivity. The difference in substrate specificity between leishmanial and mammalian TAT and the importance of this enzyme in parasite metabolism suggest that it may be a useful target in the development of new drugs against leishmaniasis.
format Online
Article
Text
id pubmed-4014323
institution National Center for Biotechnology Information
language English
publishDate 2014
publisher International Union of Crystallography
record_format MEDLINE/PubMed
spelling pubmed-40143232014-06-05 Structure of tyrosine aminotransferase from Leishmania infantum Moreno, M. A. Abramov, A. Abendroth, J. Alonso, A. Zhang, S. Alcolea, P. J. Edwards, T. Lorimer, D. Myler, P. J. Larraga, V. Acta Crystallogr F Struct Biol Commun Structural Communications The trypanosomatid parasite Leishmania infantum is the causative agent of visceral leishmaniasis (VL), which is usually fatal unless treated. VL has an incidence of 0.5 million cases every year and is an important opportunistic co-infection in HIV/AIDS. Tyrosine aminotransferase (TAT) has an important role in the metabolism of trypanosomatids, catalyzing the first step in the degradation pathway of aromatic amino acids, which are ultimately converted into their corresponding l-2-oxoacids. Unlike the enzyme in Trypanosoma cruzi and mammals, L. infantum TAT (LiTAT) is not able to transaminate ketoglutarate. Here, the structure of LiTAT at 2.35 Å resolution is reported, and it is confirmed that the presence of two Leishmania-specific residues (Gln55 and Asn58) explains, at least in part, this specific reactivity. The difference in substrate specificity between leishmanial and mammalian TAT and the importance of this enzyme in parasite metabolism suggest that it may be a useful target in the development of new drugs against leishmaniasis. International Union of Crystallography 2014-04-25 /pmc/articles/PMC4014323/ /pubmed/24817714 http://dx.doi.org/10.1107/S2053230X14007845 Text en © Moreno et al. 2014 http://creativecommons.org/licenses/by/2.0/uk/ This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
spellingShingle Structural Communications
Moreno, M. A.
Abramov, A.
Abendroth, J.
Alonso, A.
Zhang, S.
Alcolea, P. J.
Edwards, T.
Lorimer, D.
Myler, P. J.
Larraga, V.
Structure of tyrosine aminotransferase from Leishmania infantum
title Structure of tyrosine aminotransferase from Leishmania infantum
title_full Structure of tyrosine aminotransferase from Leishmania infantum
title_fullStr Structure of tyrosine aminotransferase from Leishmania infantum
title_full_unstemmed Structure of tyrosine aminotransferase from Leishmania infantum
title_short Structure of tyrosine aminotransferase from Leishmania infantum
title_sort structure of tyrosine aminotransferase from leishmania infantum
topic Structural Communications
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4014323/
https://www.ncbi.nlm.nih.gov/pubmed/24817714
http://dx.doi.org/10.1107/S2053230X14007845
work_keys_str_mv AT morenoma structureoftyrosineaminotransferasefromleishmaniainfantum
AT abramova structureoftyrosineaminotransferasefromleishmaniainfantum
AT abendrothj structureoftyrosineaminotransferasefromleishmaniainfantum
AT alonsoa structureoftyrosineaminotransferasefromleishmaniainfantum
AT zhangs structureoftyrosineaminotransferasefromleishmaniainfantum
AT alcoleapj structureoftyrosineaminotransferasefromleishmaniainfantum
AT edwardst structureoftyrosineaminotransferasefromleishmaniainfantum
AT lorimerd structureoftyrosineaminotransferasefromleishmaniainfantum
AT mylerpj structureoftyrosineaminotransferasefromleishmaniainfantum
AT larragav structureoftyrosineaminotransferasefromleishmaniainfantum